Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700035343

Trial Profile

Clinical Trials Insight: 700035343

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 14 Jan 2010

At a glance

  • Drugs Influenza virus delta-NS1 vaccine (Primary)
  • Indications Influenza A virus H5N1 subtype
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors AVIR Green Hills Biotechnology
  • Most Recent Events

    • 14 Jan 2010 Status changed from recruiting to active, no longer recruiting.
    • 13 Jan 2010 Data from this trial is expected in quarter 1 2010, as reported by AVIR Green Hills Biotechnology.
    • 16 Jul 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top